Search Results - "Agmon‐Fishman, I."

Clinical utility of expanded non‐invasive prenatal screening compared with chromosomal microarray analysis in over 8000 pregnancies without major structural anomaly by Maya, I., Salzer Sheelo, L., Brabbing‐Goldstein, D., Matar, R., Kahana, S., Agmon‐Fishman, I., Klein, C., Gurevitch, M., Basel‐Salmon, L., Sagi‐Dain, L.

“…ABSTRACT Objectives To evaluate the theoretical added value of two types of non‐invasive prenatal screening (NIPS) expansions in pregnancies without major…”
Get full text

Cut‐off value of nuchal translucency as indication for chromosomal microarray analysis by Maya, I., Yacobson, S., Kahana, S., Yeshaya, J., Tenne, T., Agmon‐Fishman, I., Cohen‐Vig, L., Shohat, M., Basel‐Vanagaite, L., Sharony, R.

“…ABSTRACT Objectives An association between isolated, increased nuchal translucency thickness (NT) and pathogenic findings on chromosomal microarray analysis…”
Get full text

Chromosomal microarray analysis in fetuses with aberrant right subclavian artery by Maya, I., Kahana, S., Yeshaya, J., Tenne, T., Yacobson, S., Agmon‐Fishman, I., Cohen‐Vig, L., Levi, A., Reinstein, E., Basel‐Vanagaite, L., Sharony, R.

“…ABSTRACT Objective To evaluate the association between aberrant right subclavian artery (ARSA), with or without additional risk factors for aneuploidy or…”
Get full text